Filings under BEAT by Biotelemetry, Inc. (CIK 0001574774) from Oct 15, 2013 to Feb 9, 2021 belong to a different issuer and are not shown. Filings under BEAT by CardioNet, Inc. (CIK 0001113784) from Mar 25, 2008 to Jul 26, 2013 belong to a different issuer and are not shown.
The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 24, 2026 | Persen Kenneth Harry | Chief Technology Officer | Grant(A) | 106K | — | $0 |
| Jul 24, 2026 | Cruickshank Tim | CFO | Grant(A) | 168K | — | $0 |
| Jul 24, 2026 | Vajdic Branislav | President, Director | Grant(A) | 261K | — | $0 |
| Jun 15, 2026 | Vajdic Branislav | President, Director | Grant(A) | 2.8M | — | $0 |
| Apr 16, 2026 | Elfrink Willem | Director | Buy(P) | 188K | $0.80 | $150K |
| Apr 16, 2026 | Cruickshank Tim | CFO | Buy(P) | 31K | $0.80 | $25K |
| Apr 16, 2026 | ENO Robert Paul | President | Buy(P) | 13K | $0.80 | $10K |
| Apr 16, 2026 | Ortigas-Wedekind Marga | Director | Buy(P) | 25K | $0.80 | $20K |
| Apr 16, 2026 | Vajdic Branislav | Director | Buy(P) | 31K | $0.80 | $25K |
| Apr 16, 2026 | Jaff Michael R | Director | Buy(P) | 31K | $0.80 | $25K |
| Apr 16, 2026 | Strome Mark E | Director | Buy(P) | 750K | $0.80 | $600K |
| Apr 16, 2026 | Ferrari Richard | Director | Buy(P) | 58K | $0.80 | $46K |
| Feb 9, 2026 | ENO Robert Paul | President | Grant(A) | 55K | — | $0 |
| Feb 9, 2026 | de Urioste George | Director | Grant(A) | 52K | — | $0 |
| Feb 9, 2026 | Nelson Kenneth Warwick III | Director | Grant(A) | 17K | — | $0 |
| Feb 9, 2026 | Elfrink Willem | Director | Grant(A) | 52K | — | $0 |
| Feb 9, 2026 | Cruickshank Tim | CFO | Grant(A) | 53K | — | $0 |
| Feb 9, 2026 | Vajdic Branislav | President, Director | Grant(A) | 62K | — | $0 |
| Feb 9, 2026 | Jaff Michael R | Director | Grant(A) | 21K | — | $0 |
| Feb 9, 2026 | Strome Mark E | 10% Owner | Grant(A) | 41K | — | $0 |
| Feb 9, 2026 | Ferrari Richard | Director | Grant(A) | 50K | — | $0 |
| Feb 9, 2026 | Ortigas-Wedekind Marga | Director | Grant(A) | 45K | — | $0 |
| Dec 18, 2025 | de Urioste George | Director | Sell(S) | 33K | $2.83 | $94K |
| Dec 17, 2025 | de Urioste George | Director | Sell(S) | 24K | $3.68 | $88K |
| Dec 17, 2025 | Strome Mark E | 10% Owner | Sell(S) | 250K | $3.58 | $895K |
| Apr 7, 2025 | Vajdic Branislav | President, Director | Grant(A) | 180K | — | $0 |
| Apr 7, 2025 | Persen Kenneth Harry | Chief Technology Officer | Grant(A) | 20K | — | $0 |
| Apr 7, 2025 | ENO Robert Paul | Chief Executive Officer | Grant(A) | 320K | — | $0 |
| Apr 7, 2025 | Cruickshank Tim | Chief Financial Officer | Grant(A) | 150K | — | $0 |
| Feb 14, 2025 | Cruickshank Tim | CFO | Buy(P) | 18K | $1.70 | $30K |
| Feb 14, 2025 | Ferrari Richard | Director | Buy(P) | 29K | $1.70 | $50K |
| Sep 25, 2024 | Cruickshank Tim | CFO | Grant(A) | 400K | $2.28 | $912K |
| Sep 6, 2024 | de Urioste George | Director | Sell(S) | 2K | $2.34 | $4K |
| Aug 30, 2024 | de Urioste George | Director | Sell(S) | 6K | $2.31 | $13K |
| Aug 27, 2024 | de Urioste George | Director | Sell(S) | 2K | $2.26 | $5K |
| Aug 26, 2024 | de Urioste George | Director | Sell(S) | 300 | $2.38 | $714 |
| Aug 23, 2024 | de Urioste George | Director | Sell(S) | 3K | $2.30 | $6K |
| Jun 12, 2024 | Ortigas-Wedekind Marga | Director | Grant(A) | 33K | — | $0 |
| Jun 12, 2024 | Ferrari Richard | Director | Grant(A) | 44K | — | $0 |
| Jun 12, 2024 | de Urioste George | Director | Grant(A) | 33K | — | $0 |
| Jun 12, 2024 | Strome Mark E | 10% Owner | Grant(A) | 33K | — | $0 |
| Jun 12, 2024 | Elfrink Willem | Director | Grant(A) | 33K | — | $0 |
| Jun 12, 2024 | Jaff Michael R | Director | Grant(A) | 33K | — | $0 |
| Jun 12, 2024 | Nelson Kenneth Warwick III | Director | Grant(A) | 33K | — | $0 |
| Sep 29, 2023 | de Urioste George | Director | Sell(S) | 6K | $2.06 | $11K |
| Sep 28, 2023 | de Urioste George | Director | Sell(S) | 8K | $2.04 | $16K |
| Sep 27, 2023 | de Urioste George | Director | Sell(S) | 2K | $2.11 | $4K |
| Sep 26, 2023 | de Urioste George | Director | Sell(S) | 5K | $2.09 | $10K |
| Sep 22, 2023 | de Urioste George | Director | Sell(S) | 2K | $2.21 | $5K |
| Sep 21, 2023 | de Urioste George | Director | Sell(S) | 100 | $2.41 | $241 |
| Sep 20, 2023 | de Urioste George | Director | Sell(S) | 883 | $2.46 | $2K |
| Sep 18, 2023 | de Urioste George | Director | Sell(S) | 5K | $2.46 | $12K |
| Sep 15, 2023 | de Urioste George | Director | Sell(S) | 4K | $2.43 | $10K |
| Sep 14, 2023 | de Urioste George | Director | Sell(S) | 5K | $2.17 | $11K |
| Sep 13, 2023 | de Urioste George | Director | Sell(S) | 2K | $1.90 | $4K |
| Sep 13, 2023 | de Urioste George | Director | Sell(S) | 3K | $1.95 | $6K |
| Aug 2, 2023 | ENO Robert Paul | President | Grant(A) | 357K | — | $0 |
| Aug 2, 2023 | Vajdic Branislav | CHIEF EXECUTIVE OFFICER | Grant(A) | 796K | — | $0 |
| Aug 2, 2023 | Persen Kenneth Harry | Chief Technology Officer | Grant(A) | 252K | — | $0 |
| Jul 13, 2023 | de Urioste George | Director | Grant(A) | 24K | — | $0 |
| Jul 13, 2023 | Ortigas-Wedekind Marga | Director | Grant(A) | 24K | — | $0 |
| Jul 13, 2023 | Nelson Kenneth Warwick III | Director | Grant(A) | 24K | — | $0 |
| Jul 13, 2023 | Ferrari Richard | Director | Grant(A) | 32K | — | $0 |
| Jul 13, 2023 | Strome Mark E | 10% Owner | Grant(A) | 24K | — | $0 |
| Jul 13, 2023 | Elfrink Willem | Director | Grant(A) | 24K | — | $0 |
| May 14, 2023 | Vajdic Branislav | Chief Executive Officer | Grant(A) | 398K | — | $0 |
| May 14, 2023 | Persen Kenneth Harry | Chief Technology Officer | Grant(A) | 169K | — | $0 |
| May 14, 2023 | ENO Robert Paul | President | Grant(A) | 179K | — | $0 |
| Mar 21, 2023 | Persen Kenneth Harry | Chief Technology Officer | Grant(A) | 60K | — | $0 |
| Feb 12, 2023 | Elfrink Willem | Director | Conversion(C) | 44K | — | $0 |
| Feb 10, 2023 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 184 | — | $0 |
| Feb 10, 2023 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 727 | $3.68 | $3K |
| Feb 10, 2023 | Vajdic Branislav | CHIEF EXECUTIVE OFFICER | Option exercise(M) | 1K | — | $0 |
| Feb 10, 2023 | Vajdic Branislav | CHIEF EXECUTIVE OFFICER | Option exercise(M) | 5K | $3.68 | $19K |
| Feb 9, 2023 | Elfrink Willem | Director | Disposed to issuer(D) | 125K | — | $0 |
| Feb 9, 2023 | Elfrink Willem | Director | Conversion(C) | 4K | $2.75 | $10K |
| Feb 9, 2023 | Elfrink Willem | Director | Conversion(C) | 4K | $2.75 | $10K |
| Dec 2, 2022 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 760 | — | $0 |
| Dec 2, 2022 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 760 | — | $0 |
| Nov 2, 2022 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 759 | — | $0 |
| Nov 2, 2022 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 759 | — | $0 |
| Oct 2, 2022 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 760 | — | $0 |
| Oct 2, 2022 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 760 | — | $0 |
| Sep 16, 2022 | Persen Kenneth Harry | Chief Technology Officer | Grant(A) | 80K | — | $0 |
| Sep 2, 2022 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 757 | — | $0 |
| Sep 2, 2022 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 757 | — | $0 |
| Aug 1, 2022 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 757 | — | $0 |
| Aug 1, 2022 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 757 | — | $0 |
| Jul 15, 2022 | Elfrink Willem | Director | Grant(A) | 55K | — | $0 |
| Jul 15, 2022 | Ortigas-Wedekind Marga | Director | Grant(A) | 55K | — | $0 |
| Jul 15, 2022 | Ferrari Richard | Director | Grant(A) | 74K | — | $0 |
| Jul 15, 2022 | de Urioste George | Director | Grant(A) | 55K | — | $0 |
| Jul 5, 2022 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 757 | — | $0 |
| Jul 5, 2022 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 757 | — | $0 |
| Jun 16, 2022 | Elfrink Willem | Director | Grant(A) | 50K | — | — |
| Jun 15, 2022 | Vajdic Branislav | Chief Executive Officer | Grant(A) | 359K | — | $0 |
| Jun 15, 2022 | Baumel Alan | Chief Operating Officer | Grant(A) | 38K | — | $0 |
| Jun 15, 2022 | Brounstein Richard | Chief Financial Officer | Grant(A) | 80K | — | $0 |
| Jun 15, 2022 | Hunt Jon Patrick | Chief Business Officer | Grant(A) | 72K | — | $0 |
| Jun 2, 2022 | Brounstein Richard | Chief Financial Officer | Option exercise(M) | 757 | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Issuer: HeartBeam, Inc., SEC CIK 0001779372. The symbol on a Form 4 is typed by the filer, so this page follows the issuer with the newest filing under BEAT and shows every filing by that issuer. Earlier filings under the same symbol by another issuer are left out.
Coverage: Form 4 filings indexed 2006-01-02 → 2026-09-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).
Connected pages for BEAT